Daily Archives: Sep 27, 2011

The Role of Insulin Pens in Addressing Barriers to Insulin Therapy

The advantages of insulin pens may reduce resistance to initiating and adhering to insulin therapy. Many patients resist insulin initiation due to concerns about complexity or a general resistance to injections; many patients’ concerns about insulin initiation may stem from perceptions about the pain and inconvenience of using vials and …

Read More »

Dr. Stanley Schwartz on Early Insulin Use

Stanley_Schwartz

Stanley Schwartz, MD, FACP, FACE, shares his views on early insulin initiation. Insulin is the most effective agent available for lowering glycemia. If given in appropriate doses, insulin may decrease any elevated HbA1c to, or close to, the therapeutic goal. However, insulin therapy is associated with weight gain of 2 …

Read More »

Editor’s Note: Our One-Year Anniversary

This week marks one year since we started delivering our Diabetes Clinical Mastery Series newsletter, and Steve, Andrew, Heather and I appreciate the great support you have given us. According to your emails, the Homerun Slides have provided great materials for your talks, and there have been enough comments about …

Read More »

Early Use of Insulin to Improve Beta Cell Preservation

Image_1

By David Joffe, BSPharm, CDE; Steve Freed, BSPharm CPT; Brandon Flohr, PharmD, and Vanessa Cepero, PharmD, CVS Pharmacy Type 2 diabetes is a heterogeneous disorder, characterized by glucotoxicity, beta cell dysfunction and decreased insulin sensitivity. Presence of amyloid deposits in the islets and decreased beta cell mass are the pathological hallmark …

Read More »